ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023

Go back to ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023

Immucell Corp (ICCC) Reports Q3 Loss of $0.12

November 13, 2023 4:22 PM EST

Immucell Corp (NASDAQ: ICCC) reported Q3 EPS of ($0.12). Revenue for the quarter came in at $5.4 million, versus $0 reported last year.

For earnings history and earnings-related data on Immucell Corp (ICCC) click here.

... More